The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring

@inproceedings{Yata2017TheAO,
  title={The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring},
  author={Yusuke Yata and Michihiro Hosojima and Hideyuki Kabasawa and Tomomi Ishikawa and Ryohei Kaseda and Noriaki Iino and Yoshiki Suzuki and Akihiko Saito and Ichiei Narita},
  booktitle={Internal medicine},
  year={2017}
}
Objective The administration of glucocorticoids usually causes a mild increase in fasting glucose levels and a greater dose-dependent increase in postprandial values in patients without pre-existing diabetes mellitus. Patients with persistent hyperglycemia due to glucocorticoid therapy sometimes require insulin therapy, which might result in increased… CONTINUE READING